See what questions
a doctor would ask.
Undiagnosed and untreated prostate cancer often moves to the bones (metastitises). Treatment involves suppression of the male hormone (androgens) but after 1 or 2 years, the therapy becomes ineffective as the cancer is no longer fuelled by androgens. Researchers are testing a new therapy whereby low-dose radiation or chemotherapy is done before T cells are transferred to prevent them being attacked. These T cells are genetically programmed to be tumor antigen specific and were found to be capable of slowing tumor growth, increasing survival rate and even curing some mice. This immunotherapy treatment offers hope for those suffering from metastatic prostate cancer as well as other malignant tumors.
Source: summary of medical news story as reported by Medical News Today
About: Novel treatment for matastatic prostate cancer being developed
Date: 16 December 2004
Source: Medical News Today
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City